Anaconda Biomed is a medical device start-up that develops the next generation of catheters to perform efficient mechanical thrombectomies.
Anaconda BioMed has raised $56.0M in total funding. The most recent round was Series C. The last funding was announced in September 2026.
Anaconda BioMed's investors include Cofides, Omega Funds, Asabys Partners, Ysios Capital, Centre for the Development of Industrial Technology (CDTI).
Anaconda BioMed is headquartered in Barcelona, Spain.
Anaconda Biomed is a medical device start-up that develops the next generation of catheters to perform efficient mechanical thrombectomies.
Anaconda BioMed is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Anaconda BioMed — Funding & Investors." VCBacked, September 23, 2026, https://www.vcbacked.co/company/anaconda-biomed. Accessed November 11, 2026.
VCBacked. (2026). Anaconda BioMed — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/anaconda-biomed
{{cite web |title=Anaconda BioMed — Funding & Investors |url=https://www.vcbacked.co/company/anaconda-biomed |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Anaconda BioMed? Request a listing update